Minireviews
Copyright ©The Author(s) 2019.
World J Hematol. Dec 20, 2019; 8(1): 1-9
Published online Dec 20, 2019. doi: 10.5315/wjh.v8.i1.1
Figure 1
Figure 1 Final treatment outcome (n = 34). MS-LCH: Multisystem Langerhans cell histiocytosis; SS-LCH: Single-system Langerhans cell histiocytosis; NAD: Nonactive disease; ADR: Active disease regressive; ADS: Active disease stable; PD: Progression disease.